MOTS-c Dosage: How Much to Take, When & How
Overview
MOTS-c is a 16-amino acid mitochondrial-derived peptide that works primarily by activating AMPK signaling pathways, which enhances glucose uptake, fatty acid oxidation, and mitochondrial biogenesis. As a research peptide not approved for human use, dosing protocols are based on observational data from research settings and biohacker communities rather than large-scale clinical trials.
The standard dosing range is 5–10 mg administered 3–5 times per week via subcutaneous injection. However, optimal dosing varies significantly based on your individual goals, body weight, experience level, and specific health objectives. This guide provides practical dosing frameworks to help you understand how much to take, when to take it, and how to administer it safely.
Cost Context: MOTS-c typically costs $80–$220 per month depending on dosage frequency and vendor, making it one of the more affordable research peptides for ongoing supplementation.
Standard Dosing Protocol
The consensus dosing protocol in research and biohacking communities is straightforward:
Dose per injection: 5–10 mg Frequency: 3–5 times per week Route: Subcutaneous injection Typical weekly dose: 15–50 mg per week
Most individuals start at the lower end (5 mg, 3x per week = 15 mg/week) and adjust based on tolerance and response. A standard 8–12 week cycle is typical for initial assessment, though some practitioners use longer protocols.
Injection Volume & Concentration
MOTS-c is commonly supplied as a lyophilized powder that requires reconstitution with bacteriostatic water. A typical 10 mg vial reconstituted with 1 mL of bacteriostatic water yields 10 mg/mL concentration, making dosing straightforward:
- 5 mg dose = 0.5 mL injection
- 10 mg dose = 1.0 mL injection
Always verify the concentration provided by your supplier and adjust volumes accordingly.
Dosing by Goal
While MOTS-c has plausible mechanisms for multiple health benefits, the evidence tier varies significantly. Dosing recommendations below reflect both the strength of evidence and practical experience in research communities.
Metabolic Health & Insulin Sensitivity (Tier 2 Evidence)
Recommended dose: 5–7 mg, 4–5x per week (20–35 mg/week)
MOTS-c activates AMPK signaling and improves glucose uptake, making this application one of the most mechanistically supported. Observational data shows that circulating levels are elevated in individuals with metabolic dysfunction, suggesting supplementation may help normalize these pathways.
Start with 5 mg four times weekly. If well-tolerated after 2–3 weeks, increase to 7 mg per injection or add a fifth injection day. Duration: 8–12 weeks minimum to assess metabolic improvements.
Monitoring: Track fasting glucose, energy levels, and appetite regulation. Hypoglycemia risk exists, particularly in individuals already managing blood glucose closely—monitor closely and adjust if needed.
Fat Loss Support (Tier 2 Evidence)
Recommended dose: 5–10 mg, 5x per week (25–50 mg/week)
MOTS-c shows mechanistic promise for fat loss through AMPK activation and mitochondrial enhancement, though human evidence is limited and sometimes paradoxical. Higher-frequency dosing may optimize metabolic signaling throughout the week.
Use 5 mg daily (injected 5 days per week with 2 rest days) or escalate to 7–10 mg depending on tolerance. Longer cycles (12–16 weeks) are typically recommended for body composition changes. Combine with resistance training and caloric deficit for optimal results.
Note: One observational study found that obese individuals had higher circulating MOTS-c than lean controls, suggesting endogenous upregulation in metabolic stress. This underscores the importance of combining peptide use with lifestyle strategies rather than relying on supplementation alone.
Muscle Performance & Recovery (Tier 2 Evidence)
Recommended dose: 7–10 mg, 4–5x per week (28–50 mg/week)
Evidence shows MOTS-c correlates with muscle performance in humans and facilitates sarcolemma integrity through TRIM72 interaction. Higher doses may optimize this effect, particularly when combined with resistance training.
Inject 7–10 mg on training days plus 1–2 additional days weekly. Time injections 2–4 hours before intense training when possible to maximize the window of AMPK activation and mitochondrial upregulation. Cycles of 12–16 weeks support measurable performance gains.
Injury Recovery & Bone Healing (Tier 2 Evidence)
Recommended dose: 7–10 mg, 5x per week (35–50 mg/week)
Animal models show MOTS-c accelerates bone fracture healing and supports musculoskeletal recovery. Higher frequency dosing may sustain the anabolic signaling needed for repair.
For acute injury or post-surgical recovery, use 10 mg daily (5 injections per week). Duration depends on injury severity but typically 12–16 weeks. Once healing is evident, taper to maintenance dosing (5 mg, 3x per week).
Anti-Inflammation & Immune Support (Tier 2 Evidence)
Recommended dose: 5–7 mg, 4–5x per week (20–35 mg/week)
MOTS-c demonstrates consistent anti-inflammatory effects in animal and limited human studies, with reduced levels observed in asthma, acute coronary syndrome, and autoimmune conditions. Standard to moderate dosing supports inflammatory modulation without excessive stimulation.
Use 5 mg four times weekly as a baseline. Those with active inflammatory conditions may increase to 7 mg or 5x weekly dosing. Expect 4–8 weeks before meaningful inflammatory marker improvements.
Cardiovascular & Heart Health (Tier 3 Evidence)
Recommended dose: 5–7 mg, 3–4x per week (15–28 mg/week)
MOTS-c shows reduced levels in acute myocardial infarction patients and predicts cardiac events, suggesting therapeutic potential. However, evidence remains observational. Conservative dosing is prudent until more human data emerges.
Start with 5 mg three times weekly. Increase to four weekly injections or 7 mg per injection if well-tolerated. Monitor cardiovascular parameters and discuss supplementation with a cardiologist, especially if you have existing heart disease or take anticoagulants.
Metabolic Neuroprotection & Cognition (Tier 2 Evidence)
Recommended dose: 5 mg, 3–4x per week (15–20 mg/week)
MOTS-c transcript levels are reduced in Alzheimer's disease and show neuroprotective mechanisms in rodent models. Conservative dosing reflects emerging rather than robust human evidence.
Use 5 mg three times weekly as a baseline. Cycles should be longer (16–20 weeks) to assess cognitive biomarkers and subjective mental clarity. Consider combining with other neuroprotective compounds and lifestyle strategies (exercise, sleep, cognitive training).
How to Administer
MOTS-c is supplied exclusively as a research compound for injection—oral, intranasal, or transdermal delivery is not standard.
Subcutaneous Injection Technique
-
Reconstitution: Reconstitute lyophilized MOTS-c powder with bacteriostatic water per supplier instructions. Gently swirl (do not shake) until fully dissolved. Store reconstituted peptide at 2–8°C and use within 30 days.
-
Site selection: Pinch skin on abdomen, outer thigh, or upper arm. Inject at a 45–90-degree angle into the subcutaneous layer (between skin and muscle, not intramuscularly).
-
Injection: Use a 29–31 gauge insulin syringe. Draw up the calculated volume, cleanse the injection site with an alcohol swab, and inject slowly. Withdraw the needle and apply gentle pressure with a clean gauze pad.
-
Rotation: Rotate injection sites daily to minimize local irritation and inflammation. A pattern like: Monday abdomen, Tuesday thigh, Wednesday abdomen, etc. works well.
-
Timing: Inject in the morning for consistency, or 2–4 hours before exercise if timing to workouts.
Storage & Stability
- Lyophilized powder: Store at room temperature (avoid heat and light) for 1–2 years depending on packaging.
- Reconstituted solution: Refrigerate at 2–8°C; typically stable for 30 days.
- Pre-filled syringes: If using pre-filled syringes, store at 2–8°C and use within the expiration date.
Cycling & Timing
MOTS-c is generally not cycled like hormonal compounds, but strategic cycling optimizes results and minimizes adaptation.